Skip to main content
ClinicalTrials.govcontrolled

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

ClinicalTrials.gov study NCT06369285. IPD Sharing: YES. Countries: 3. Publications: 0.

ShareScore

28/100

Overall dataset sharing score

Score breakdown

These five areas show where the dataset supports — or may limit — practical reuse.

Stewardship
16
Harmonization
8
Access
0
Reuse readiness
0
Engagement
4

Topics

Dataset details

Repository
ClinicalTrials.gov
Published
February 11, 2026
License
IPD-YES
DOI
clinicaltrials.gov/NCT06369285
Open full record on ShareScore ↗

Scored with release 0.9.0

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.